ActivX Biosciences and Kyorin Pharmaceutical Sign Second Drug Discovery and Development Collaboration Agreement.
Business Wire › January 13, 2004
Linked as:
Extract
ActivX Biosciences and Kyorin Pharmaceutical Sign Second Drug Discovery and Development Collaboration Agreement.
Business Editors/Health/Medical Writers
BIOWIRE2K LA JOLLA, Calif.--(BUSINESS WIRE)--Jan. 13, 2004 ActivX Biosciences, Inc., a privately held biotechnology company applying novel chemical technologies and h...See the full content of this document
Sponsored links
